Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Italian Multicenter Study on Accuracy of 18F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma.
Cistaro A, Cassalia L, Ferrara C, Quartuccio N, Evangelista L, Bianchi M, Fagioli F, Bisi G, Baldari S, Zanella A, Pillon M, Zucchetta P, Burei M, Sala A, Guerra L, Guglielmo P, Burnelli R, Panareo S, Scalorbi F, Rambaldi I, Piccardo A, Garaventa A, Familiari D, Fornito MC, Lopci E, Mascarin M, Altini C, Ferrari C, Perillo T, Santoro N, Borsatti E, Rubini G. Cistaro A, et al. Among authors: rambaldi i. Clin Lymphoma Myeloma Leuk. 2018 Jun;18(6):e267-e273. doi: 10.1016/j.clml.2018.04.002. Epub 2018 Apr 14. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29739722
FDG PET/CT in autoimmune pancreatitis.
Nanni C, Romagnoli R, Rambaldi I, Caroli P, Matteucci F, Ambrosini V, Re G, Fanti S. Nanni C, et al. Among authors: rambaldi i. Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1264-5. doi: 10.1007/s00259-014-2699-5. Epub 2014 Feb 22. Eur J Nucl Med Mol Imaging. 2014. PMID: 24562645 No abstract available.
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma.
Zamagni E, Nanni C, Mancuso K, Tacchetti P, Pezzi A, Pantani L, Zannetti B, Rambaldi I, Brioli A, Rocchi S, Terragna C, Martello M, Marzocchi G, Borsi E, Rizzello I, Fanti S, Cavo M. Zamagni E, et al. Among authors: rambaldi i. Clin Cancer Res. 2015 Oct 1;21(19):4384-90. doi: 10.1158/1078-0432.CCR-15-0396. Epub 2015 Jun 15. Clin Cancer Res. 2015. PMID: 26078390
Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).
Nanni C, Zamagni E, Versari A, Chauvie S, Bianchi A, Rensi M, Bellò M, Rambaldi I, Gallamini A, Patriarca F, Gay F, Gamberi B, Cavo M, Fanti S. Nanni C, et al. Among authors: rambaldi i. Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):414-21. doi: 10.1007/s00259-015-3200-9. Epub 2015 Oct 16. Eur J Nucl Med Mol Imaging. 2016. PMID: 26475305
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease.
Zamagni E, Nanni C, Gay F, Pezzi A, Patriarca F, Bellò M, Rambaldi I, Tacchetti P, Hillengass J, Gamberi B, Pantani L, Magarotto V, Versari A, Offidani M, Zannetti B, Carobolante F, Balma M, Musto P, Rensi M, Mancuso K, Dimitrakopoulou-Strauss A, Chauviè S, Rocchi S, Fard N, Marzocchi G, Storto G, Ghedini P, Palumbo A, Fanti S, Cavo M. Zamagni E, et al. Among authors: rambaldi i. Leukemia. 2016 Feb;30(2):417-22. doi: 10.1038/leu.2015.291. Epub 2015 Oct 22. Leukemia. 2016. PMID: 26490489
Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
Zattoni F, Incerti E, Colicchia M, Castellucci P, Panareo S, Picchio M, Fallanca F, Briganti A, Moschini M, Gallina A, Karnes JR, Lowe V, Fanti S, Schiavina R, Rambaldi I, Ficarra V, Evangelista L. Zattoni F, et al. Among authors: rambaldi i. Abdom Radiol (NY). 2018 Sep;43(9):2391-2399. doi: 10.1007/s00261-017-1443-6. Abdom Radiol (NY). 2018. PMID: 29302738
18F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis-A Multicenter Retrospective Study.
Zattoni F, Incerti E, Dal Moro F, Moschini M, Castellucci P, Panareo S, Picchio M, Fallanca F, Briganti A, Gallina A, Fanti S, Schiavina R, Brunocilla E, Rambaldi I, Lowe V, Karnes JR, Evangelista L. Zattoni F, et al. Among authors: rambaldi i. Cancers (Basel). 2019 May 20;11(5):700. doi: 10.3390/cancers11050700. Cancers (Basel). 2019. PMID: 31137599 Free PMC article.
10-Year Clinical Experience With 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients.
Zattoni F, Ravelli I, Rensi M, Capobianco D, Borsatti E, Baresic T, Chiaravalloti A, Schillaci O, Alongi P, Bartolotta TV, Rambaldi I, Bartolomei M, Farsad M, Tredici M, Donner D, Chierichetti F, Trifirò G, Brugola E, Burei M, Dal Moro F, Cecchin D, Evangelista L. Zattoni F, et al. Among authors: rambaldi i. Clin Nucl Med. 2020 Aug;45(8):594-603. doi: 10.1097/RLU.0000000000003125. Clin Nucl Med. 2020. PMID: 32558711
Diagnostic Contribution of Contrast-Enhanced CT as Compared with Unenhanced Low-Dose CT in PET/CT Staging and Treatment Response Assessment of 18F-FDG-Avid Lymphomas: A Prospective Study.
Marchetti L, Perrucci L, Pellegrino F, Baroni L, Merlo A, Tilli M, Rambaldi I, Maietti E, Carnevale A, Bartolomei M, Giganti M. Marchetti L, et al. Among authors: rambaldi i. J Nucl Med. 2021 Oct;62(10):1372-1379. doi: 10.2967/jnumed.120.259242. Epub 2021 Mar 12. J Nucl Med. 2021. PMID: 33712534 Free article.
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer.
Zattoni F, Artioli P, Burei M, Chiaravalloti A, Chierichetti F, Donner D, Panareo S, Rambaldi I, Schillaci O, Dal Moro F, Evangelista L. Zattoni F, et al. Among authors: rambaldi i. Q J Nucl Med Mol Imaging. 2023 Jun;67(2):167-173. doi: 10.23736/S1824-4785.21.03366-5. Epub 2021 Sep 3. Q J Nucl Med Mol Imaging. 2023. PMID: 34477346
36 results